Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honglei Kang

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 2022
Inhibition of FAAH suppresses RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss partially through repressing the IL17 pathwayMeipeng Zhu, Qian Guo, Honglei Kang, et al.
Cell Metabolism|April 3, 2024
A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axisYimin Dong, Honglei Kang, Renpeng Peng, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 2022
Inhibition of FAAH suppresses RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss partially through repressing the IL17 pathwayMeipeng Zhu, Qian Guo, Honglei Kang, et al.
Cell Metabolism|April 3, 2024
A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axisYimin Dong, Honglei Kang, Renpeng Peng, et al.
Pageof 5